高血压肾病

CKD患者耳聋的患病率在西医不同临床诊断中分布有差异，而糖尿病肾病及高血压肾病为其主要影响因素。

The deafness morbidity of CKD patients have differences in the different clinical diagnosis , and distribution of diabetic nephropathy and hypertensive renal disease are the main influence factors . 6 .

结论YNBY给药后能够显著减轻SHR肾脏炎症反应和氧化应激水平，YNBY可能在防治高血压肾病方面具有一定的疗效。

ConclusionYNBY can reduce the inflammatory status and oxidative stress of SHR kidney , which may serve as the base for the advanced therapeutic utility of YNBY in hypertensive renal disease .

原发性高血压肾病患者血清胱抑素C和尿微量白蛋白检测的临床意义

Clinical Significance of Serum Cystatin C and Urine Microalbumin Levels in Patients with Primary Hypertension Nephropathy

前列腺素E1（凯时）注射液对高血压肾病的作用

Effects of prostaglandin E_1 on hypertensive nephropathy

原发性肾小球疾病和高血压肾病患者血清Ald水平比较

Comparison of Serum Aldosterone Levels in Patients with Primary Glomerular Diseases with Those in Patients with Hypertensive Nephropathy

血、尿α1-MG、β2-MG、尿ALB在早期高血压肾病中的变化

Changes of α _1-MG 、β _2-MG in blood and urine , and urine ALB in early hypertensive kidney disease

微量白蛋白尿（microalbuminuria，MAU）是反映肾小球疾病和损伤的一项非常灵敏的指标，在糖尿病及高血压肾病方面已使用多年。

Microalbuminuria is a very sensitive indicator of glomerular disease and injury , which has been used in diabetic and hypertensive nephropathy for many years .

老年高血压肾病组CD62P、CD63的表达组间差异有显著性（P<005），且随血压分级水平升高而递增。

The expression level of CD62P and CD63 on platelet in patients had significant difference between groups of hypertension stage and increased in parallel with stage level .

结论α1MG、ALB的检测对于糖尿病肾病、高血压肾病的早期诊断以及肾功能损伤程度、部位的判定具有一定的价值。

Conclusions The tests of α 1 MG and ALB are of vital importance in clinic at the early diagnosis of patients with renal diabetes and renal hypertention as well as the injury of renal function .

镇肝熄风汤治疗高血压肾病临床研究

Clinical Study on Zhengan Xifeng Decoction in Preventing and Treating Hypertensive Nephropathy

什么是高血压肾病？

Hypertensie Nephropathy is a disease of the kidneys .

血尿微量蛋白在高血压肾病早期诊断中的意义

Significance of Micro-protein in Blood Urine for Early Diagnosis of Hypertensive Kidney Disease

肾脏早期损害指标的联合分析对高血压肾病的诊断价值

Diagnositic Significance of Combined Analysis of Markers Representing Early Renal Impairment to Hypertensive Nephropathy

目的：观察灯盏花素配合西药治疗高血压肾病的临床疗效。

Objective : Investigation of the clinical effect of Breviscapine on treating hypertensive nephrosis .

苯那普利与科素亚联合应用对高血压肾病的保护作用

The Protective Effect of the Combination of Benazepril and Losartan on Renal Injury in SHRs

目的探讨高血压肾病的临床表现、早期诊断及药物治疗。

Objective To discuss clinical manifestations , early diagnosis and drug treatment in hypertensive renal disease .

结论肾功能轻、中度损害的高血压肾病患者服用替米沙坦，不仅可有效降低血压，还可以更好地降低尿蛋白排泄量。

Conclusion Telmisartan can decrease blood pressure effectively and reduce the excretion rate of urinary protein .

结论：灯盏花素是治疗高血压肾病的安全、有效药物之一。

Conclusion : Breviscapine is one of the safe and effective medicines to treat hypertensive nephrosis .

目的观察红花注射液对早期高血压肾病尿微量蛋白的影响。

Objective To investigate the effects of safflower injection on uromicroprotein of early stage hypertensive nephropathy .

高血压肾病起病隐匿，在早期阶段，常规检查很难发现阳性结果。

In early stage , the hypertensive injury of kidney is difficulty to be detected with routine tests clinically .

病因前三位是：原发性肾炎48.2%，糖尿病肾病16.7%，高血压肾病7.9%。

The incidence of primary glomerulonephritis , diabetic nephropathy and hypertensive nephropathy were 48.2 % , 16.7 % and 7.9 % respectively .

结论：老年高血压肾病时血小板活化增强，推测其在老年高血压肾病发生发展中起重要作用。

Conclusion The platelet activity increases in hypertensive nephropathy . It is suggested that activated platelets may play a major role in the development of hypertensive nephropathy .

糖尿病肾脏疾病、高血压肾病、尿路梗阻是导致糖尿病住院患者慢性肾脏病的主要病因，分别占病因构成的57.31%、9.91%、9.61%。

Diabetic kidney disease , Hypertensive nephropathy , Urinary tract obstruction were the leading cause of CKD , respectively accounting for 57.31 % 、 9.91 % 、 9.61 % .

原发病：糖尿病肾病26例，肾炎33例，高血压肾病18例，梗阻性肾病14例，多囊肾3例。

Primary disease : diabetic nephropathy in 26 cases , 33 cases of nephritis , hypertensive nephropathy in 18 cases , 14 cases of obstructive nephropathy , polycystic kidney disease in 3 cases .

终末期肾脏疾病透析患者主要病因为慢性肾小球肾炎（52.0%），其次为糖尿病肾病（16.0%），高血压肾病（13.2%），梗阻性肾病（9.0%）；

Main etiological factor of ESRD patients were chronic glomerulonephritis ( CGN )( 52.0 % ), followed by diabetic nephropathy ( 16.0 % ), hypertensive nephropathy ( 13.2 % ), and obstructive nephropathy ( 9.0 % ) .

引起慢性肾衰竭的有原发性肾脏病和继发性肾脏病，原发性肾脏病包括慢性肾小球肾炎、慢性肾盂肾炎等，继发性肾脏病以糖尿病肾病、高血压肾病、狼疮性肾病多见。

There are primary renal disease and secondary renal disease that can cause CRF , primary renal diseases is including chronic glomerulonephritis and Chronic Pyelonephritis ; secondary renal disease including Diabetic Nephropathy ( DN ), Hypertensive Nephropathy and Lupus Nephropathy .

目的通过检测2型糖尿病（DM）患者血尿酸水平，探讨高尿酸血症与2型DM合并高血压、肾病的关系。

Objective To discuss the relationship among hyperuricemia , diabetes-combined high blood pressure and nephropathy , by detecting the level of the blood uric acid ( UA ) in the patients with type 2 diabetes ( T2DM ) .

尿酸和C-反应蛋白与2型糖尿病高血压和肾病的相关性

Relation of uric acid and C-reactive protein with type 2 diabetic hypertension and nephropathy

高血压和肾病综合征基因治疗的实验研究

Gene Therapy for Hypertension and Nephrotic Syndrome

有没有被诊断出高血压、肾病、哮喘、或是呼吸困难？

Have you ever been diagnosed with high-blood pressure ? Kidney disease ? What about asthma ?